Ultra-processed food has become public enemy number one, and plant-based meat has been caught in the crossfire. Here's ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

Teens are being prescribed Ozempic more than ever before — and some doctors are worried about what the trend could mean.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Key Takeaways Novo Nordisk stock rose on Tuesday after the Financial Times reported that an activist investor is building a ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Clever Culture Systems is gaining traction with its AI-enabled tool to ensure that ultra-sterile drug facilities stay that way.

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...